isoniazid has been researched along with Anti-MuSK Myasthenia Gravis in 1 studies
Hydra: A genus of freshwater polyps in the family Hydridae, order Hydroida, class HYDROZOA. They are of special interest because of their complex organization and because their adult organization corresponds roughly to the gastrula of higher animals.
hydrazide : Compounds derived from oxoacids RkE(=O)l(OH)m (l =/= 0) by replacing -OH by -NRNR2 (R groups are commonly H). (IUPAC).
| Excerpt | Relevance | Reference |
|---|---|---|
| "A 47-year-old woman who had been treated for systemic lupus erythematosus (SLE) with myasthenia gravis (MG) was admitted to our hospital with acute onset of severe anemia after administration of isoniazid." | 7.76 | Isoniazid-triggered pure red cell aplasia in systemic lupus erythematosus complicated with myasthenia gravis. ( Eguchi, K; Ida, H; Imanishi, D; Kawakami, A; Motomura, M; Nakamura, H; Okada, A; Yamasaki, S, 2010) |
| "A 47-year-old woman who had been treated for systemic lupus erythematosus (SLE) with myasthenia gravis (MG) was admitted to our hospital with acute onset of severe anemia after administration of isoniazid." | 3.76 | Isoniazid-triggered pure red cell aplasia in systemic lupus erythematosus complicated with myasthenia gravis. ( Eguchi, K; Ida, H; Imanishi, D; Kawakami, A; Motomura, M; Nakamura, H; Okada, A; Yamasaki, S, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nakamura, H | 1 |
| Okada, A | 1 |
| Kawakami, A | 1 |
| Yamasaki, S | 1 |
| Ida, H | 1 |
| Motomura, M | 1 |
| Imanishi, D | 1 |
| Eguchi, K | 1 |
1 other study available for isoniazid and Anti-MuSK Myasthenia Gravis
| Article | Year |
|---|---|
Isoniazid-triggered pure red cell aplasia in systemic lupus erythematosus complicated with myasthenia gravis.
Topics: Antitubercular Agents; Cyclosporine; Drug Therapy, Combination; Erythroblasts; Female; Humans; Immun | 2010 |